Showing 1 - 18 results of 18 for search 'D V Bukhanova', query time: 0.04s Refine Results
  1. 1
    Herpes zoster virus infection and rheumatic diseases: Current state of the problem

    Herpes zoster virus infection and rheumatic diseases: Current state of the problem by D. V. Bukhanova, B. S. Belov

    Published 2016-09-01
    Get full text
    Article
  2. 2
    Joint damage in hiv positive patients

    Joint damage in hiv positive patients by D. V. Bukhanova, B. S. Belov

    Published 2018-05-01
    Get full text
    Article
  3. 3
    Infectious comorbidities in patients with rheumatoid arthritis: Status praesens

    Infectious comorbidities in patients with rheumatoid arthritis: Status praesens by B. S. Belov, G. M. Tarasova, D. V. Bukhanova

    Published 2019-09-01
    Get full text
    Article
  4. 4
    Chikungunya fever: rheumatological aspects

    Chikungunya fever: rheumatological aspects by В. S. Belov, D. V. Bukhanova, G. M. Tarasova

    Published 2018-09-01
    Get full text
    Article
  5. 5
    Mycotic infections in rheumatology

    Mycotic infections in rheumatology by B. S. Belov, G. M. Tarasova, D. V. Bukhanova

    Published 2017-04-01
    Get full text
    Article
  6. 6
    Lower respiratory tract infections in rheumatic diseases

    Lower respiratory tract infections in rheumatic diseases by B. S. Belov, D. V. Bukhanova, G. M. Tarasova

    Published 2018-04-01
    Get full text
    Article
  7. 7
    BIOLOGICAL THERAPY AND INFECTION IN RHEUMATOID ARTHRITIS PATIENTS: MODERN ASPECTS

    BIOLOGICAL THERAPY AND INFECTION IN RHEUMATOID ARTHRITIS PATIENTS: MODERN ASPECTS by B. S. BELOV, M. S. NAUMTSEVA, G. M. TARASOVA, D. V. BUKHANOVA

    Published 2016-12-01
    Get full text
    Article
  8. 8
    Vaccination in rheumatology: Evolution of views on the problem

    Vaccination in rheumatology: Evolution of views on the problem by B S Belov, M S Sergeeva, G M Tarasova, D V Bukhanova

    Published 2017-05-01
    Get full text
    Article
  9. 9
    TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES

    TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES by B. S. Belov, M. S. Naumtseva, G. M. Tarasova, D. V. Bukhanova

    Published 2016-12-01
    Get full text
    Article
  10. 10
    PROCALCITONIN TESTING IN RHEUMATOLOGY

    PROCALCITONIN TESTING IN RHEUMATOLOGY by D. V. Bukhanova, B. S. Belov, G. M. Tarasova, A. G. Dilbaryan

    Published 2017-12-01
    Get full text
    Article
  11. 11
    Significance of serum procalcitonin for differentiating infections from rheumatic diseases

    Significance of serum procalcitonin for differentiating infections from rheumatic diseases by G. M. Tarasova, B. S. Belov, A. G. Dilbaryan, D. V. Bukhanova, S. I. Glukova

    Published 2018-11-01
    Get full text
    Article
  12. 12
    VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS

    VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS by A. E. Karateev, N. V. Gontarenko, A. V. Tsurgan, A. A. Abramkin, L. D. Vorobyeva, D. V. Bukhanova

    Published 2016-07-01
    Get full text
    Article
  13. 13
    INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS by G. M. Tarasova, B. S. Belov, D. V. Bukhanova, M. V. Cherkasova, S. K. Solovyev, E. A. Aseeva, T. M. Reshetnyak, T. V. Popkova

    Published 2018-09-01
    Get full text
    Article
  14. 14
    Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study

    Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study by D. V. Bukhanova, M. S. Sergeeva, B. S. Belov, G. M. Tarasova, M. V. Cherkasova, Yu. A. Muraviev, G. V. Lukina, N. V. Demidova

    Published 2018-12-01
    Get full text
    Article
  15. 15
    SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS

    SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS by D. V. Bukhanova, В. S. Belov, G. M. Tarasova, Sh. F. Erdes, T. V. Dubinina, G. V. Lukina, M. V. Cherkasova, M. E. Diatroptov

    Published 2018-07-01
    Get full text
    Article
  16. 16
    Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)

    Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova) by D. V. Bukhanova, B. S. Belov, G. M. Tarasova, S. K. Soloviev, L. P. Ananyeva, T. V. Popkova, A. V. Gordeev, Yu. V. Muravyov, S. I. Glukhova

    Published 2019-06-01
    Get full text
    Article
  17. 17
    Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis

    Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis by E. S. Kuvardin, D. Yu. Andreev, P. A. Yastrebov, V. Yu. Myachikova, D. V. Bukhanova, D. V. Karpova, K. N. Malikov, M. Yu. Samsonov, A. L. Maslyanskiy

    Published 2022-11-01
    Get full text
    Article
  18. 18
    Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases

    Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases by D. V. Bukhanova, B. S. Belov, G. M. Tarasova, Sh. Erdes, T. V. Dubinina, G. V. Lukina, N. V. Demidova, A. V. Volkov, N. N. Yudkina, M. V. Cherkasova, M. E. Diatroptov

    Published 2018-07-01
    Get full text
    Article

Search Tools: